Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease (original) (raw)

• Kim WR, Brown RS, Terrault NA, et al.: Burden of liver disease in the United States: summary of a workshop. Hepatology 2002, 36:227–241.
  Article PubMed Google Scholar
• Grant BF, Hartford TC, Dawson DA, et al.: Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992. Epidemiologic Bulletin No. 35. Alcohol Health Res World 1994, 18:243–248.
  Google Scholar
• Mandayam S, Jamal MM, Morgan T: Epidemiology of alcoholic liver disease. Semin Liv Dis 2004, 24:217–232. This review article discusses ethnic and gender differences in alcoholic liver disease, the spectrum of severity of this disease, and the prevalence of alcoholic cirrhosis mortality.
  Article Google Scholar
• Corrao G, Ferrari P, Zambon A, Torchio P: Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries. J Stud Alcohol 1997, 58:486–494.
  PubMed CAS Google Scholar
• Robertson I: Safe drinking. BMJ 1994, 308:346.
  Google Scholar
• McCullough AJ, O’Connor JF: Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998, 93:2022–2036.
  Article PubMed CAS Google Scholar
• Maher JJ: Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 2002, 13:31–39.
  PubMed Google Scholar
• Bellantani S, Saccoccio G, Masutti F, et al.: Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000, 132:112–117.
  Google Scholar
• Chedid A, Mendenhall CL, Tosch T, et al.: Significance of megamitochondria in alcoholic liver disease. Gastroenterology 1986, 90:1858–1864.
  PubMed CAS Google Scholar
• Teli MR, Day CP, Burt AD, et al.: Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995, 346:987–990.
  Article PubMed CAS Google Scholar
• Pares A, Caballeria J, Bruguera M, et al.: Histological course of alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986, 2:33–42.
  Article PubMed CAS Google Scholar
• Raynard B, Balian A, Fallik D, et al.: Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002, 35:635–638.
  Article PubMed Google Scholar
• Naveau S, Giraud V, Borotto E, et al.: Excess weight risk factor for alcoholic liver disease. Hepatology 1997, 25:108–111.
  Article PubMed CAS Google Scholar
• Galambos JT: Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology 1972, 63:1026–1035.
  PubMed CAS Google Scholar
• Cortez-Pinto H, Baptista A, Camilo ME: Nonalcoholic steatohepatitis- a long-term follow up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 2003, 48:1909–1913. This follow-up study of 105 steatohepatitis patients compares survival rates for various subgroups: nonalcoholic versus alcoholic and ambulatory versus hospitalized.
  Article PubMed Google Scholar
• Borowsky SA, Strome S, Lott E: Continued heavy drinking and survival in alcoholic cirrhosis. Gastroenterology 1981, 80:1405–1409.
  PubMed CAS Google Scholar
• Propst A, Propst T, Zangerl G, et al.: Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995, 40:1805–1815.
  Article PubMed CAS Google Scholar
• Chedid A, Mendenhall CL, Gartside P, et al.: Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991, 86:210–216.
  PubMed CAS Google Scholar
• Veldt BJ, Laine’ F, Guillygomarc’h A, et al.: Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 2002, 36:93–98.
  Article PubMed Google Scholar
• Orrego H, Blake JE, Blendis LM, et al.: Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987, 92:208–214.
  PubMed CAS Google Scholar
• Menon KV, Gores GJ, Shah VH: Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc 2001, 76:1021–1029.
  PubMed CAS Google Scholar
• Starzl TE, Van Thiel D, Tzakis AG, et al.: Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988, 260:25–42.
  Article Google Scholar
• Mackie J, Groves K, Hoyle A: Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001, 7:418–427.
  Article PubMed CAS Google Scholar
• Yurdaydin C, Cetinkaya H, Bozkaya H: Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001, 46:1022–1028.
  Article PubMed Google Scholar
• Schafer DF, Sorrell MF: Hepatocellular carcinoma. Lancet 1999, 33:1253–1257.
  Article Google Scholar
• Poynard T, Aubert A, Lazizi Y, et al.: Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 1991, 13:896–900.
  PubMed CAS Google Scholar
• Akriviadis EA, Llovet JM, Efremidis SC, et al.: Hepatocellular carcinoma. Br J Surg 1998, 85:1319–1331.
  Article PubMed CAS Google Scholar
• McCullough AJ: The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004, 8:521–533. This article gives a thorough review of the clinical features, diagnosis, and natural history of NAFLD. It also provides a detailed listing of patient demographics compiled from the literature.
  Article PubMed Google Scholar
• Ruhl C, Everhart J: Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004, 8:500–519.
  Article Google Scholar
• Bellentani S, Tiribelli C: The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001, 35:531–537.
  Article PubMed CAS Google Scholar
• Haynes P, Liangpunsakul S, Chalasani N: Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis 2004, 8:535–547.
  Article PubMed Google Scholar
• Lavine J, Schwimmer J: Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004, 8:549–558. This review article summarizes the data on pediatric NASH in terms of prevalence, demographics, clinical presentation, histology, pathogenesis, and treatment. It also highlights important differences between pediatric and adult fatty liver disease.
  Article PubMed Google Scholar
• Clark JM, Diehl AM: Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003, 124:248–250.
  Article PubMed Google Scholar
• Harrison SA, Di Bisceglie AM: Advances in the understanding and treatment of nonalcoholic fatty liver disease. Drugs 2003, 63:2379–2394. This thorough review article discusses the epidemiology, clinical presentation, diagnosis, pathogenesis, natural history, and treatment of NAFLD.
  Article PubMed CAS Google Scholar
• Harrison SA, Torgerson S, Hayashi PH: The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003, 98:2042–2047.
  Article PubMed Google Scholar
• Teli MR, James OFW, Burt AD, et al.: The natural history of nonalcoholic fatty liver disease: a follow-up study. Hepatology 1995, 22:1714–1719.
  Article PubMed CAS Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, et al.: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413–1419.
  Article PubMed CAS Google Scholar
• Falck-Ytter Y, Younossi Z, Marchesini G, McCullough A: Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001, 21:17–26.
  Article PubMed CAS Google Scholar
• Wanless I, Lentz J: Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12:1106–1110.
  Article PubMed CAS Google Scholar
• Dixon J, Bhathal P, O’Brien P: Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91–100.
  Article PubMed CAS Google Scholar
• Lee RG: Nonalcoholic steatohepatitis: a study of 39 patients. Hum Pathol 1989, 20:594–598.
  Article PubMed CAS Google Scholar
• Powell EE, Cooksley WG, Hanson R, et al.: The natural history of nonalcoholic steatohepatitis: a follow-up study of fortytwo patients for up to 21 years. Hepatology 1990, 11:74–80.
  Article PubMed Google Scholar
• Bacon BR, Farahvash MJ, Janney CG, et al.: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994, 107:1103–1109.
  PubMed CAS Google Scholar
• Angulo P, Keach JC, Batts KP, et al.: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356–1362.
  Article PubMed CAS Google Scholar
• Dixon JB, Bhathal PS, O’Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91–100.
  Article PubMed CAS Google Scholar
• Harrison SA, Oliver DA, Torgerson S, et al.: NASH: clinical assessment of 501 patients from two separate academic medical centers with validation of a clinical scoring system for advanced hepatic fibrosis [abstract]. Hepatology 2003, 34:511A.
  Article Google Scholar
• Chitturi S, Weltman M, Farrell GC, et al.: HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002, 36:142–149.
  Article PubMed CAS Google Scholar
• Zamin JI: The importance of AST/ALT rate in nonalcoholic steatohepatitis diagnosis. Arq Gastroenterol 2002, 39:22–26.
  PubMed Google Scholar
• George DK, Goldwurm S, MacDonald GA, et al.: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998, 114:311–318.
  Article PubMed CAS Google Scholar
• Ratziu V, Giral P, Charlotte F, et al.: Liver fibrosis in overweight patients. Gastroenterology 2000, 118:1117–1123.
  Article PubMed CAS Google Scholar
• Hui JM, Kench JG, Chitturi S, et al.: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003, 38:420–427. This prospective cohort study investigated the long-term morbidity and mortality of 23 patients with NASH-associated cirrhosis defined by strict clinicopathologic criteria. Subjects were followed for 84 months and compared with age- and gender-matched patients with cirrhosis from chronic HCV infection.
  Article PubMed Google Scholar
• Charlton M, Kasparova P, Weston S, et al.: Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001, 7:608–614.
  Article PubMed CAS Google Scholar
• Caldwell SH, Oelsner DH, Iezzoni JC, et al.: Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664–669.
  Article PubMed CAS Google Scholar
• Poonawala A, Nair SP, Thulavath PJ: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000, 32:689–692.
  Article PubMed CAS Google Scholar
• Contos MJ, Cales W, Sterling RK, et al.: Development of non-alcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001, 7:363–373.
  Article PubMed CAS Google Scholar
• Ratziu V, Bonyhay L, Di Martino V, et al.: Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485–1493.
  Article PubMed Google Scholar
• Cotrim HP, Parana R, Braga E, Lya L: Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Amer J Gastroenterol 2000, 95:3018–3019.
  Article CAS Google Scholar
• Zen Y, Katayanagi K, Tsuneyama K, et al.: Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001, 51:127–131.
  Article PubMed CAS Google Scholar
• Shimada M, Hashimoto E, Taniai M, et al.: Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37:154–160.
  Article PubMed Google Scholar
• Mori S: Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterology 2004, 39:391–396.
  Article Google Scholar
• Bugianesi E, Leone N, Vanni E, et al.: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123:134–140.
  Article PubMed Google Scholar
• Marrero J, Fontana R, Su G, et al.: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349–1354.
  PubMed Google Scholar